Cavan M. Redmond - Jun 24, 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Director
Signature
/s/ Cavan M. Redmond
Stock symbol
OCX
Transactions as of
Jun 24, 2022
Transactions value $
$0
Form type
4
Date filed
7/19/2022, 04:05 PM
Previous filing
Mar 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Options Exercise $0 +10K +9.02% $0.00 121K Jun 24, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Restricted Stock Units Options Exercise $0 -10K -100% $0.00* 0 Jun 24, 2022 Common Stock 10K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units vested on June 24, 2022.